TrAC Trends in Analytical Chemistry,
Год журнала:
2023,
Номер
161, С. 116986 - 116986
Опубликована: Фев. 20, 2023
The
amalgamation
of
computer-like
capabilities
and
portability
modern
smartphones
has
fuelled
their
implementation
as
detectors
interfaces
in
emerging
smartphone-based
(bio)sensors
(SbSs)
for
e.g.
healthcare,
point-of-need,
food
safety,
environmental
science,
forensics
systems.
SbSs
intrinsically
carry
great
potential
consumer
diagnostics,
future
‘citizen
science’
approaches,
which
have
far-reaching
implications
the
technological,
legal,
ethical
aspects
associated
with
research,
development,
deployment
SbSs.
In
this
review
(part
2
a
pair
papers),
we
evaluated
pertinent
literature
on
issues
concerning
development
validation
SbSs,
address
social
impact.
Finally,
insights
gleaned
are
combined
set
recommendations
to
guide
ethical,
sustainable,
efficient
Chemical Society Reviews,
Год журнала:
2023,
Номер
52(24), С. 8500 - 8530
Опубликована: Янв. 1, 2023
This
review
explores
various
point-of-care
optical
diagnostic
systems
combined
with
microdevices
developed
during
the
recent
COVID-19
pandemic
for
clinical
diagnostics.
Vaccines,
Год журнала:
2023,
Номер
11(2), С. 408 - 408
Опубликована: Фев. 10, 2023
The
coronavirus
2019
(COVID-19)
pandemic
was
caused
by
a
positive
sense
single-stranded
RNA
(ssRNA)
severe
acute
respiratory
syndrome
2
(SARS-CoV-2).
However,
other
human
coronaviruses
(hCoVs)
exist.
Historical
pandemics
include
smallpox
and
influenza,
with
efficacious
therapeutics
utilized
to
reduce
overall
disease
burden
through
effectively
targeting
competent
host
immune
system
response.
is
composed
of
primary/secondary
lymphoid
structures
initially
eight
types
cell
types,
many
subtypes,
traversing
membranes
utilizing
signaling
cascades
that
contribute
towards
clearance
pathogenic
proteins.
Other
proteins
discussed
cluster
differentiation
(CD)
markers,
major
histocompatibility
complexes
(MHC),
pleiotropic
interleukins
(IL),
chemokines
(CXC).
historical
concepts
immunity
are
the
innate
adaptive
systems.
represented
T
cells,
B
antibodies.
macrophages,
neutrophils,
dendritic
complement
system.
viruses
can
affect
regulate
cycle
progression
for
example,
in
cancers
papillomavirus
(HPV:
cervical
carcinoma),
Epstein-Barr
virus
(EBV:
lymphoma),
Hepatitis
C
(HB/HC:
hepatocellular
carcinoma)
Leukemia
Virus-1
(T
leukemia).
Bacterial
infections
also
increase
risk
developing
cancer
(e.g.,
Talanta,
Год журнала:
2023,
Номер
265, С. 124818 - 124818
Опубликована: Июнь 18, 2023
Surface
Enhanced
Raman
Spectroscopy
is
increasingly
used
as
a
sensitive
bioanalytical
tool
for
detection
of
variety
analytes
ranging
from
viruses
and
bacteria
to
cancer
biomarkers
toxins,
etc.
This
comprehensive
review
describes
principles
operation
compares
the
performance
immunoassays
aptamer
assays
with
scattering
(SERS)
each
other
some
bioassay
methods,
including
ELISA
fluorescence
assays.
Both
immuno-
aptamer-based
are
categorized
into
assay
on
solid
substrates,
magnetic
nanoparticles
in
laminar
flow
or/and
strip
The
best
performing
recent
examples
category
described
text
illustrated
figures.
average
performance,
particularly,
limit
(LOD)
those
methods
reflected
9
tables
manuscript
LODs
calculated
compared.
We
found
out
that,
average,
there
advantage
terms
LOD
SERS
(0.
pM
median
88
papers)
vs
(1.7
51
papers).
also
tabulated
analyzed
clinical
immune
assays,
where
selectivity,
specificity,
accuracy
reported,
we
summarized
examples.
reviewed
challenges
real-life
application,
non-specific
protein
binding,
nanoparticle
aggregation,
limited
nanotag
stability,
sometimes,
relatively
long
time
results,
proposed
solutions
discussed
review.
Overall,
this
may
be
interesting
not
only
chemist,
but
medical
life
science
researchers
who
interested
improvement
bioanalyte
diagnostics.
Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences,
Год журнала:
2023,
Номер
381(2257)
Опубликована: Авг. 23, 2023
We
conducted
a
systematic
literature
review
of
general
population
testing,
contact
tracing,
case
isolation
and
quarantine
interventions
to
assess
their
effectiveness
in
reducing
SARS-CoV-2
transmission,
as
implemented
real-world
settings.
designed
broad
search
strategy
aimed
identify
peer-reviewed
studies
any
design
provided
there
was
quantitative
measure
on
transmission
outcome.
Studies
that
assessed
the
effect
testing
or
diagnosis
disease
outcomes
via
treatment,
but
did
not
outcome,
were
included.
focused
among
rather
than
specific
settings;
these
from
anywhere
world
published
time
after
1
January
2020
until
end
2022.
From
26
720
titles
abstracts,
1181
reviewed
full
text,
25
met
our
inclusion
criteria.
These
included
one
randomized
control
trial
(RCT)
remaining
24
analysed
empirical
data
made
some
attempt
for
confounding.
categorized
by
type
intervention:
tracing
(seven
studies);
strategies
(12
isolating
cases/contacts
(four
'test,
trace,
isolate'
(TTI)
part
package
(two
studies).
None
rated
at
low
risk
bias
many
serious
bias,
particularly
due
likely
presence
uncontrolled
confounding
factors,
which
major
challenge
assessing
independent
effects
TTI
observational
studies.
factors
are
be
expected
during
an
on-going
pandemic,
when
emphasis
epidemic
burden
design.
Findings
suggested
important
public
health
role
followed
isolation,
especially
where
mass
serial
used
reduce
transmission.
Some
most
compelling
analyses
came
examining
fine-grained
within-country
tracing;
while
broader
compared
behaviour
between
countries
also
often
found
led
reduced
mortality,
this
universal.
There
limited
evidence
benefit
away
home
environment.
One
study,
RCT,
showed
daily
contacts
could
viable
replace
lengthy
contacts.
Based
scarcity
robust
evidence,
we
able
draw
firm
conclusions
about
impact
different
contexts.
While
majority
scale
is
only
available
scenarios
hence
necessarily
generalizable.
Our
therefore
emphasizes
need
conduct
experimental
help
inform
optimal
Work
needed
support
such
context
future
emerging
epidemics,
along
with
assessments
cost-effectiveness
interventions,
beyond
scope
will
critical
decision-making.
This
article
theme
issue
'The
non-pharmaceutical
COVID-19
pandemic:
evidence'.
Diagnostics,
Год журнала:
2024,
Номер
14(5), С. 519 - 519
Опубликована: Фев. 29, 2024
The
urgent
need
for
accurate
COVID-19
diagnostics
has
led
to
the
development
of
various
SARS-CoV-2
detection
technologies.
Real-time
reverse
transcriptase
polymerase
chain
reaction
(RT-qPCR)
remains
a
reliable
viral
gene
technique,
while
other
molecular
methods,
including
nucleic
acid
amplification
techniques
(NAATs)
and
isothermal
techniques,
provide
diverse
effective
approaches.
Serological
assays,
detecting
antibodies
in
response
infection,
are
crucial
disease
surveillance.
Saliva-based
immunoassays
show
promise
surveillance
purposes.
efficiency
antibody
varies,
with
IgM
indicating
recent
exposure
IgG
offering
prolonged
detectability.
Various
rapid
tests,
lateral-flow
immunoassays,
present
opportunities
quick
diagnosis,
but
their
clinical
significance
requires
validation
through
further
studies.
Challenges
include
variations
specificity
sensitivity
among
testing
platforms
evolving
assay
sensitivities
over
time.
antigens,
particularly
N
S
proteins,
play
role
diagnostic
methods.
Innovative
approaches,
such
as
nanozyme-based
assays
specific
nucleotide
aptamers,
offer
enhanced
flexibility.
In
conclusion,
ongoing
advancements
methods
contribute
global
effort
combating
pandemic.
Journal of Medical Virology,
Год журнала:
2022,
Номер
94(12), С. 5858 - 5866
Опубликована: Авг. 27, 2022
Abstract
To
rapidly
identify
individuals
infected
with
severe
acute
respiratory
syndrome
coronavirus‐2
(SARS‐CoV‐2)
and
control
the
spread
of
coronavirus
disease
(COVID‐19),
there
is
an
urgent
need
for
highly
sensitive
on‐site
virus
detection
methods.
A
clustered
regularly
interspaced
short
palindromic
repeat
(CRISPR)/CRISPR‐associated
protein
(Cas)‐based
molecular
diagnostic
method
was
developed
this
purpose.
Here,
a
CRISPR
system‐mediated
lateral
flow
assay
(LFA)
SARS‐CoV‐2
established
based
on
multienzyme
isothermal
rapid
amplification,
CRISPR‐Cas13a
nuclease,
LFA.
improve
limit
(LoD),
crispr
RNA,
amplification
primer,
probe
were
screened,
in
addition
to
concentrations
various
components
reaction
system.
The
LoD
improved
0.25
copy/μl
both
fluorescence‐
immunochromatography‐based
assays.
enhance
quality
CRISPR‐based
LFA
method,
glyceraldehyde‐3‐phosphate
dehydrogenase
detected
as
reference
using
triple‐line
strip
design
strip.
In
total,
52
COVID‐19‐positive
101
COVID‐19‐negative
clinical
samples
examined
by
reverse
transcription
polymerase
chain
(RT‐PCR)
tested
immunochromatographic
technique.
Results
revealed
100%
consistency,
indicating
comparable
effectiveness
our
that
RT‐PCR.
conclusion,
approach
significantly
improves
sensitivity
reliability
CRISPR‐mediated
provides
crucial
tool
SARS‐CoV‐2.
IEEE Access,
Год журнала:
2023,
Номер
11, С. 83264 - 83277
Опубликована: Янв. 1, 2023
Chest
X-ray
images
are
among
the
most
common
diagnostic
tools
for
detecting
and
managing
bronchopneumonia
lung
abnormalities,
such
as
those
caused
by
COVID-19.
However,
interpreting
these
requires
significant
expertise,
misinterpretations
can
result
in
false
negatives
or
positives.
Deep
learning
techniques
have
recently
been
highly
effective
analyzing
medical
images,
including
chest
X-rays.
In
this
study,
we
propose
two
deep
approaches
to
classify
localize
different
COVID-19,
on
X-rays,
which
include
multi-classification
object
detection
models
that
identify
presence
of
disease
other
abnormalities.
The
proposed
trained
a
large
dataset
from
sick
people
(including
COVID-19
patients)
validated
an
independent
test
set.
Compared
single
models,
paper
presents
ensemble
combining
multiple
detect
abnormalities
images.
Our
results
demonstrate
method
achieved
promising
both
localization
compared
state-of-the-art
methodologies.
methods
potential
assist
radiologists
diagnosis
provide
more
accurate
efficient
interpretation,
thereby
improving
patient
outcomes
reducing
burden
healthcare
systems.